A BuiltForAI Property
Drug class profile · refreshed daily from federal data

alpha-Hydroxy Acid

1 molecule in this class, combined CY2024 Part D spend across claims. Class-level guide below for benefits decision-makers: where the money lives, where the savings live.

Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annualOrange Book: weeklyShortages: daily

Class summary at a glance.

Every drug in the alpha-Hydroxy Acid class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class
1tracked in Part D
CY24 Part D spend
combined across class
Total Rx claims
— unique beneficiaries
Generic mfrs (active)
4across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard
01
Ammonium
Part D claims (CY24) · First FDA approval:
4 generic mfrs 2 plans require PA
Low NADAC$0.060
Avg plan cost$0.067
Part D spend spread, current vs floor
Class share
0%
of class CY24 spend
View profile →

Related questions.

Q&A librarySourced · reviewed quarterly
pricingWhat is NADAC?pricingIs NADAC the same as my PBM cost?pricingWhat is spread pricing?pricingWhat is a NADAC pass-through PBM contract?pricingWhat's the difference between AWP, MAC, and NADAC?pricingWhat is a dispensing fee in a PBM contract?
Browse all canonical questions →